Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the Trump administration’s cuts to health research funding, impact on current research, and more.
Dr. Scott Gottlieb, former Commissioner of the U.S. Food and Drug Administration, is one of today’s most trusted voices in healthcare policy and pharmaceutical innovation. With deep experience at the highest levels of public health leadership, Dr. Gottlieb offers expert analysis on the evolving landscape of healthcare regulation, drug development, biopharma trends, and global market forces such as tariffs and supply chain disruption. A physician, policymaker, and thought leader, he regularly advises organizations navigating complex health and economic challenges. His insights are essential for anyone seeking clarity at the intersection of science, policy, and innovation. For speaking inquiries, contact WWSG.
Scott Gottlieb: Cost-Cutting Could Reverse Trump Drug Policy
President Trump often touted during his first term that his administration had “approved more affordable generic drugs than any administration in history.” He had good…
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb: FDA Cuts May Stall Drug Access
Scott Gottlieb writes about how ‘Cost-cutting’ may undo one of Trump’s best drug pricing achievements President Trump often touted during his first term that his…
Thought Leader: Scott Gottlieb
Dave Chokshi: Lessons from the Front Lines of the Pandemic
Dave Chokshi, who led New York City’s response to COVID-19 as health commissioner and now serves as chair of the Common Health Coalition, joins the…
Thought Leader: Dave Chokshi
